Key result
Telemedicine-based quality control for portable INR monitors demonstrates high accuracy with ~1% out-of-range results.
Observational
Yes
A structured quality control protocol for INR portable monitors is effective in maintaining device reliability and ensuring analytical data quality over time.
Answers are grounded in this paper and cite their sources.
Supports INR monitor QC protocols in practice; leaves open need for larger prospective validation before broader adoption.
INTRODUCTION: Although most guidelines for quality assessment of INR PMs recommend specific procedures, no clear regulation or methodology is required for outpatients in our country. We have developed a specific INR portable monitor (PM) quality control system within our telemedicine organization to check over time quality performances and plan corrective actions. METHODS: Based on current guidelines for laboratory QC, the following aspects were assessed: suitability of PM, defined in terms of imprecision and accuracy; intra-assay imprecision, defined according to monthly revision of Levey-Jennings cards with data from each peripheral healthcare unit (PHU), using an internal QC provided by the manufacturer (CV ± 20% considered as acceptable); quarterly accuracy study, for assessing agreement between analytical instruments, based on duplicate analysis of three samples with INR values reflecting different therapeutic ranges (differences ± 0.5 considered as acceptable); external quality assessment (NEQAS). RESULTS: In the nine PHU, 18 portable monitors were used to perform 22 929 test during year 2010. Analytical imprecision was low, showing CVs always <5%. Accuracy check showed two of 216 results out of range (0.92%), thus providing timely indication for instrument replacement. The external QC NEQAS showed optimal performance. CONCLUSION: The current protocol for INR PMs quality assessment was effective to establish and maintain a reliable control of devices, ensuring the quality of analytical data over time. National authorities should be prompted to guarantee and apply correct protocols for INR-PM use.
No takes yet. Share an insight, caveat, or question.
Testa et al. (2014) conducted an observational in Antivitamin K antagonists therapy monitoring. INR portable monitor quality control system was evaluated on Analytical imprecision and accuracy. A telemedicine-based quality control system for INR portable monitors demonstrated low analytical imprecision and high accuracy, with only 0.92% of results out of range across 22,929 tests.
Synapse has enriched 10 related papers. Consider them for comparative context: